Sirtuin 1 activator SRT1720 protects against organ injury induced by intestinal ischemia-reperfusion

Shock

Volumn 45, Issue 4, 2016, Pages 359-366

  Hansen, Laura W ^a,b   Khader, Adam ^a   Yang, Weng Lang ^a,b   Prince, Jose M ^a,b   Nicastro, Jeffrey M ^a   Coppa, Gene F ^a   Wang, Ping ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Energy metabolism; Inflammation; Lung injury; Neutrophil infiltration; Oxidative stress

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MYELOPEROXIDASE; N [2 [3 (1 PIPERAZINYLMETHYL)IMIDAZO[2,1 B]THIAZOL 6 YL]PHENYL] 2 QUINOXALINECARBOXAMIDE; SIRTUIN 1; SUCCINATE DEHYDROGENASE; ENZYME ACTIVATOR; FUSED HETEROCYCLIC RINGS; SIRT1 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; INFLAMMATION; INTESTINE ISCHEMIA; LUNG INJURY; LUNG PARENCHYMA; MALE; MITOCHONDRIAL BIOGENESIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN INJURY; OXIDATIVE STRESS; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; ANIMAL; ENZYMOLOGY; INTESTINAL DISEASES; INTESTINE; METABOLISM; MOUSE; PATHOLOGY; REPERFUSION INJURY; VASCULARIZATION;

ANIMALS; ENZYME ACTIVATORS; HETEROCYCLIC COMPOUNDS, 4 OR MORE RINGS; INTESTINAL DISEASES; INTESTINES; MALE; MICE; REPERFUSION INJURY; SIRTUIN 1;

EID: 84944345297     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000448     Document Type: Conference Paper

References (35)

1. Acosta S: Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg 23(1):4-8, 2010.
2. Collard CD, Gelman S: Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 94(6):1133-1138, 2001.
3. Turnage RH, Guice KS, Oldham KT: The effects of hypovolemia on multiple organ injury following intestinal reperfusion. Shock 1(6):408-412, 1994.
4. Matsuo S, Yang WL, Aziz M, Jacob A, Wang P: Cyclic arginine-glycineaspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion. Crit Care 17(1):R19, 2013.
5. Guzel A, Kanter M, Pergel A, Erboga M: Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/ reperfusion. J Mol Histol 43(3):361-369, 2012.
6. Koksoy C, Kuzu MA, Kuzu I, Ergun H, Gurhan I: Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg 88(3):464-468, 2001.
7. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI: Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 212(6):694-700, 1990.
8. Greer R: The temporal evolution of acute respiratory distress syndrome following shock. Eur J Anaesthesiol 27(3):226-232, 2010.
9. Madesh M, Ramachandran A, Pulimood A, VadranamM, Balasubramanian KA: Attenuation of intestinal ischemia/reperfusion injury with sodium nitroprusside: studies on mitochondrial function and lipid changes. Biochim Biophys Acta 1500(2):204-216, 2000.
10. Madesh M, Bhaskar L, Balasubramanian KA: Enterocyte viability and mitochondrial function after graded intestinal ischemia and reperfusion in rats. Mol Cell Biochem 167(1-2):81-87, 1997.
11. Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT, Tschop MH: Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 92(3):1479-1514, 2012.
12. Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM: The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusioninduced acute kidney injury. Kidney Int 83(3):404-413, 2013.
13. Khader A, Yang WL, Kuncewitch M, Jacob A, Prince JM, Asirvatham JR, Nicastro JM, Coppa GF, Wang P: Sirtuin 1 activation stimulates mitochondrial biogenesis and attenuates renal injury after ischemia-reperfusion. Transplantation 98(2):148-156, 2014.
14. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al.: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450(7170):712-716, 2007.
15. Baksi A, Kraydashenko O, Zalevkaya A, Stets R, Elliott P, Haddad J, Hoffmann E, Vlasuk GP, Jacobson EW: A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Br J Clin Pharmacol 78(1):69-77, 2014.
16. Block TA, Acosta S, Bjorck M: Endovascular and open surgery for acute occlusion of the superior mesenteric artery. J Vasc Surg 52(4):959-966, 2010.
17. Funk JA, Schnellmann RG: Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1alpha activation following ischemiareperfusion injury. Toxicol Appl Pharmacol 273(2):345-354, 2013.
18. Rasbach KA, Schnellmann RG: PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem Biophys Res Commun 355(3):734-739, 2007.
19. Luciano JA, Kautza B, Darwiche S, Martinez S, Stratimirovic S,Waltz P, Sperry J, Rosengart M, Shiva S, Zuckerbraun BS: Sirtuin 1 agonist minimizes injury and improves the immune response following traumatic shock. Shock 44(suppl 1): 149-155, 2015.
20. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, et al.: Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297(1): H13-H20, 2009.
21. Virbasius JV, Scarpulla RC: Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A 91(4):1309-1313, 1994.
22. Ikeuchi M, Matsusaka H, Kang D, Matsushima S, Ide T, Kubota T, Fujiwara T, Hamasaki N, Takeshita A, Sunagawa K, et al.: Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation 112(5):683-690, 2005.
23. Farber A, Connors JP, Friedlander RM, Wagner RJ, Powell RJ, Cronenwett JL: A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemiareperfusion in mice. J Vasc Surg 30(4):752-760, 1999.
24. Chen Z,Wang G, Zhai X, Hu Y, Gao D, Ma L, Yao J, Tian X: Selective inhibition of protein kinase C beta2 attenuates the adaptor P66 Shc-mediated intestinal ischemia-reperfusion injury. Cell Death Dis 5:e1164, 2014.
25. Yucel AF, Kanter M, Pergel A, Erboga M, Guzel A: The role of curcumin on intestinal oxidative stress, cell proliferation and apoptosis after ischemia/ reperfusion injury in rats. J Mol Histol 42(6):579-587, 2011.
26. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP: Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 113(4):1246-1257, 1997.
27. Dong W, Li F, Pan Z, Liu S, Yu H, Wang X, Bi S, Zhang W: Resveratrol ameliorates subacute intestinal ischemia-reperfusion injury. J Surg Res 185(1):182-189, 2013.
28. Wu R, Dong W, Wang Z, Jacob A, Cui T, Wang P: Enhancing apoptotic cell clearance mitigates bacterial translocation and promotes tissue repair after gut ischemia-reperfusion injury. Int J Mol Med 30(3):593-598, 2012.
29. Xie J, Zhang X, Zhang L: Negative regulation of inflammation by SIRT1. Pharmacol Res 67(1):60-67, 2013.
30. Zhang F, Hu Y, Xu X, Zhai X, Wang G, Ning S, Yao J, Tian X: Icariin protects against intestinal ischemia-reperfusion injury. J Surg Res 194(1):127-138, 2015.
31. Martin TR, Nakamura M, Matute-Bello G: The role of apoptosis in acute lung injury. Crit Care Med 31(4 suppl):S184-S188, 2003.
32. Mura M, Andrade CF, Han B, Seth R, Zhang Y, Bai XH,Waddell TK, Hwang D, Keshavjee S, Liu M: Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock 28(2):227-238, 2007.
33. Sun Z, Wang X, Deng X, Borjesson A, Wallen R, Hallberg E, Andersson R: Phagocytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and reperfusion injury. Shock 13(3):209-216, 2000.
34. Montaguti P, Melloni E, Cavalletti E: Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44(4):566-570, 1994.
35. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC: Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation 120(11 suppl):S31-S36, 2009.